Search
Now showing items 1-6 of 6
Paclitaxel, Not Bevacizumab, Was Primarily Responsible for the Favorable Effects Seen in the RIBBON-2 Trial
(AMER SOC CLINICAL ONCOLOGY, 2012)
…
Insulin Therapy and Cancer-Specific Mortality in Patients With Colorectal Cancer and Diabetes
(AMER SOC CLINICAL ONCOLOGY, 2012)
…
Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma
(AMER SOC CLINICAL ONCOLOGY, 2010)
…
Prognosis of Colorectal Cancer With Peritoneal Carcinomatosis: Is a New Staging Necessary?
(AMER SOC CLINICAL ONCOLOGY, 2012)
…
Chemotherapy-Induced Spontaneous Orgasms in a Patient with Breast Cancer
(HARVEY WHITNEY BOOKS CO, 2012)
…
Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme
(INFORMA HEALTHCARE, 2012)
…